Research ArticleArticle
Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss
Ronald K. Freund, Emily S. Gibson, Huntington Potter and Mark L. Dell’Acqua
Molecular Pharmacology May 2016, 89 (5) 552-559; DOI: https://doi.org/10.1124/mol.115.103085
Ronald K. Freund
Department of Pharmacology (R.K.F., E.S.G., M.L.D.’A.), and Department Neurology (H.P.), School of Medicine, and Linda Crnic Institute for Down Syndrome (M.L.D.’A., H.P.), Anschutz Medical Campus, University of Colorado, Aurora, Colorado
Emily S. Gibson
Department of Pharmacology (R.K.F., E.S.G., M.L.D.’A.), and Department Neurology (H.P.), School of Medicine, and Linda Crnic Institute for Down Syndrome (M.L.D.’A., H.P.), Anschutz Medical Campus, University of Colorado, Aurora, Colorado
Huntington Potter
Department of Pharmacology (R.K.F., E.S.G., M.L.D.’A.), and Department Neurology (H.P.), School of Medicine, and Linda Crnic Institute for Down Syndrome (M.L.D.’A., H.P.), Anschutz Medical Campus, University of Colorado, Aurora, Colorado
Mark L. Dell’Acqua
Department of Pharmacology (R.K.F., E.S.G., M.L.D.’A.), and Department Neurology (H.P.), School of Medicine, and Linda Crnic Institute for Down Syndrome (M.L.D.’A., H.P.), Anschutz Medical Campus, University of Colorado, Aurora, Colorado
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Aβ-Mediated Synaptic Dysfunction by Eg5 Inhibition
Ronald K. Freund, Emily S. Gibson, Huntington Potter and Mark L. Dell’Acqua
Molecular Pharmacology May 1, 2016, 89 (5) 552-559; DOI: https://doi.org/10.1124/mol.115.103085
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement